Furthermore, Xiang Z–s report firstly demonstrated somatic JAK1 mutations in AML and suggested that JAK1 mutations might have function as disease-modifying mutations in AML pathogenesis [17]. This evidence concerns the gene JAK1 and acute myeloid leukemia.